Analysis of the anti-cancer effect of ethyl-p-methoxycinnamate extracted cekur (Kaempferia galanga) on cancer cell lines with wild- type and null p53
DOI:
https://doi.org/10.31436/ijohs.v1i1.16Keywords:
Ethyl-P-Methoxycinnamate, Kaempferia Galanga, p53Abstract
This study aimed to examine the in-vitro anti-cancer potential of ethyl-p-methoxycinnamate (EPMC), the major constituent of Kaempferia galanga (K. galanga) in selected human lung adenocarcinoma cells line A549 (p53 wild-type) and H1299 (p53 null). The involvement of p53 pathway in the anti-cancer effect of EPMC on selected cells was determined using MTT assay and Real-time PCR. The MTT results show that EPMC induces cytotoxicity in a dose- dependent manner in A549 cancer cell lines containing the p53 wild-type gene. Meanwhile, our RT-PCR results indicate that the apoptotic activity of EPMC does not involve the p53 pathway. Overall, these results indicate that EPMC compounds of K. galanga stimulates in vitro cytotoxic and apoptotic activity unrelated to the p53 pathway
References
Amuamuta, A., Plengsuriyakarn, T., & Na-Bangchang,K.(2017). Anticholangiocarcinoma activity and toxicity of the Kaempferia galanga Linn. Rhizome ethanolic extract. BMC Complementary and Alternative Medicine, 17(1),213.
Antony, M. L., Kim, S. H., & Singh, S. V. (2012). Critical role of p53 upregulated modulator of apoptosis in benzyl isothiocyanate-induced apoptotic cell death. PLoS One,7(2).
Bai, L., & Wang, S. (2014). Targeting apoptosis pathways for new cancer therapeutics.Annual Review of Medicine, 65,139-155.
Beckerman, R., & Prives, C. (2010). Transcriptional regulation by p53. Cold Spring Harbor Perspectives in Biology, 2(8), a000935.
Chiang, M. F., Chou, P. Y., Wang, W. J., Sze, C. I., & Chang, N. S. (2013). Tumor suppressor WWOX and p53 alterations and drug resistance in glioblastomas. Frontiers in Oncology, 3, 43.
El-Deiry, W. S. (2003). The role of p53 in chemo sensitivity and radio sensitivity. Oncogene, 22(47), 7486-7495.
Hientz, K., Mohr, A., Bhakta-Guha, D., & Efferth, T. (2017). The role of p53 in cancer drug resistance and targeted chemotherapy. Oncotarget, 8(5),8921.
Ichwan,S.J.,Al-Ani,I.M.,Bilal,H.G.,Suriyah,W.H., Taher, M., & Ikeda, M. A. (2014). Apoptotic activities of thymoquinone, an active ingredient of black seed (Nigella sativa), in cervical cancer cell lines. Chinese Journal of Physiology, 57(5),249-255.
Ichwan, S. J., Husin, A., Suriyah, W. H., Lestari, W.,Omar, M. N., &Kasmuri, A. R. (2019). Anti-neoplastic potential of ethyl-p-methoxycinnamate of Kaempferia galanga on oral cancer cell lines. Materials Today: Proceedings, 16, 2115-2121.
Khoury, K., & Domling, A. (2012). P53 mdm2 inhibitors.CurrentPharmaceutical Design, 18(30),4668-4678.
Klein, C., & Vassilev, L. T. (2004). Targeting the p53–MDM2 interaction to treat cancer. British Journal of Cancer, 91(8), 1415-1419.
Li, J., Lee, B., & Lee, A. S. (2006). Endoplasmic reticulum stress-induced apoptosis multiple pathways and activation of p53-up-regulated modulator of apoptosis (puma) and noxa by p53. Journal of Biological Chemistry, 281(11),7260-7270.
Omar, M. N., Hasali, N. H. M., & Yarmo, M. A. (2016). Cytotoxicity Activity of Biotransformed ethyl p-methoxycinnamate by Aspergillus niger. Oriental Journal of Chemistry, 32(5), 2731-2734.
Omar, M. N., Rahman, S. A., Ichwan, S. J. A.,Hasali,N.H.M.,Rasid,F.A.,&Halim,F.A. (2017). Cytotoxicity effects of extracts and essential oil of Kaempferia galanga on cervical cancer C33A cell line. Oriental Journal of Chemistry, 33,1659-1664.
Vogelstein, B., Lane, D., & Levine, A. J. (2000). Surfingthep53 network. Nature, 408(6810),307-310.
Wang, S., Zhao, Y., Bernard, D., Aguilar, A., & Kumar, S. (2012). Targeting the MDM2-p53 protein-protein interaction for new cancer therapeutics. In Protein-protein interactions (pp. 57-79). Springer, Berlin, Heidelberg.
Wang, Z., & Sun, Y. (2010). Targeting p53 for novel anticancer therapy. Translational Oncology, 3(1),1-12.
Downloads
Published
How to Cite
Issue
Section
